View Filing Data

Restructuring and Impairment Charges [Abstract]

Acquisitions

4. Acquisitions

Laddawn, Inc.

In August 2018, the Company acquired Laddawn, Inc. ("Laddawn") for a purchase price of $241 million. Laddawn is a custom bag and film manufacturer with a unique-to-industry e-commerce sales platform. The acquired business is operated in our Engineered Materials segment. To finance the purchase, the Company used existing liquidity.

The acquisition has been accounted for under the purchase method of accounting and accordingly, the purchase price has been allocated to the identifiable assets and liabilities based on the fair value at the acquisition date. The results of Laddawn have been included in the consolidated results of the Company since the date of the acquisition. The assets acquired and liabilities assumed consisted of working capital of $27 million, property and equipment of $39 million, intangible assets of $84 million, and goodwill of $91 million. The working capital includes a $3 million step up of inventory to fair value. The Company has recognized goodwill on this transaction primarily as a result of expected cost synergies, and expects goodwill to be deductible for tax purposes.

Clopay Plastic Products Company, Inc.

In February 2018, the Company acquired Clopay Plastic Products Company, Inc. ("Clopay") for a purchase price of $475 million. Clopay is an innovator in the development of printed breathable films, elastic films, and laminates with product offerings uniquely designed for applications used in a number of markets including: hygiene, healthcare, construction and industrial protective apparel. The acquired business is operated within our Health, Hygiene & Specialties segment. To finance the purchase, the Company issued $500 million aggregate principal amount of 4.5% second priority notes through a private placement offering.

The acquisition has been accounted for under the purchase method of accounting, and accordingly, the purchase price has been allocated to the identifiable assets and liabilities based on fair values at the acquisition date. The results of Clopay have been included in the consolidated results of the Company since the date of the acquisition. The Company has recognized goodwill on this transaction primarily as a result of expected cost synergies, and expects goodwill to be deductible for tax purposes. The following table summarizes the purchase price allocation and estimated fair values of the assets acquired and liabilities assumed at the date of the acquisition:

Working capital ^(a)	$	70
Property and equipment		164
Intangible assets		125
Goodwill		111
Other assets and long-term liabilities		5

^(a) Includes a $3 million step up of inventory to fair value

Accounts Receivable Factoring Agreements	9 Months Ended
Accounts Receivable Factoring Agreements	Jun. 29, 2019
Accounts Receivable Factoring Agreements [Abstract]
Accounts Receivable Factoring Agreements	5. Accounts Receivable Factoring Agreements The Company has entered into various factoring agreements, both in the U.S. and at a number of foreign subsidiaries, to sell certain receivables to unrelated third-party financial institutions. The Company accounts for these transactions in accordance with ASC 860, "Transfers and Servicing" ("ASC 860"). ASC 860 allows for the ownership transfer of accounts receivable to qualify for sale treatment when the appropriate criteria is met, which permits the Company to present the balances sold under the program to be excluded from Accounts receivable, net on the Consolidated Balance Sheets. Receivables are considered sold when (i) they are transferred beyond the reach of the Company and its creditors, (ii) the purchaser has the right to pledge or exchange the receivables, and (iii) the Company has surrendered control over the transferred receivables. In addition, the Company provides no other forms of continued financial support to the purchaser of the receivables once the receivables are sold. There were no amounts outstanding from financial institutions related to U.S. based programs at June 29, 2019 or September 29, 2018. Gross amounts factored under these U.S. based programs at June 29, 2019 and September 29, 2018 were $241 million and $162 million, respectively. The fees associated with transfer of receivables for all programs were not material for any of the periods presented.

Restructuring and Impairment Charges

9 Months Ended

Jun. 29, 2019

Restructuring and Impairment Charges

6. Restructuring and Impairment Charges

The Company incurred restructuring costs related to severance charges associated with acquisition integrations and facility exit costs. The tables below set forth the significant components of the restructuring charges recognized, by segment:

	Quarterly Period Ended				Three Quarterly Periods Ended
	June 29, 2019		June 30, 2018		June 29, 2019		June 30, 2018
Engineered Materials	$	—	$	2	$	1	$	4
Health, Hygiene & Specialties		1		4		13		26
Consumer Packaging		1		1		4		3
Consolidated	$	2	$	7	$	18	$	33

The table below sets forth the activity with respect to the restructuring accrual at June 29, 2019:

	Employee Severance and Benefits			Facility Exit Costs			Non-cash Impairment Charges			Total
Balance at September 29, 2018	$	9		$	4		$	—		$	13
Charges		7			4			7			18
Non-cash asset impairment		—			—			(7	)		(7	)
Cash payments		(13	)		(3	)		—			(16	)
Balance at June 29, 2019	$	3		$	5		$	—		$	8

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities

9 Months Ended

Jun. 29, 2019

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities

7. Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities

The following table sets forth the totals included in Accrued expenses and other current liabilities on the Consolidated Balance Sheets:

	June 29, 2019		September 29, 2018
Derivative instruments	$	138	$	—
Employee compensation		99		113
Accrued taxes		66		72
Rebates		60		58
Interest		41		49
Tax receivable agreement obligation		12		16
Restructuring		8		13
Accrued operating expenses		98		95
	$	522	$	416

The following table sets forth the totals included in Other long-term liabilities on the Consolidated Balance Sheets:

	June 29, 2019		September 29, 2018
Derivative instruments	$	79	$	12
Uncertain tax positions		67		67
Deferred purchase price		45		40
Pension liability		42		45
Lease retirement obligation		41		39
Sale-lease back deferred gain		20		21
Transition tax		17		18
Tax receivable agreement obligation		10		23
Other		24		24
	$	345	$	289

Long-Term Debt

9 Months Ended

Jun. 29, 2019

Long-Term Debt [Abstract]

Long-Term Debt

8. Long-Term Debt

Long-term debt consists of the following:

Facility	Maturity Date	June 29, 2019			September 29, 2018
Term loan	February 2020 ^(a)	$	450		$	800
Term loan	January 2021		814			814
Term loan	October 2022		1,545			1,545
Term loan	January 2024		489			493
Revolving line of credit	May 2024		—			—
5 ¹/₂% Second Priority Senior Secured Notes	May 2022		500			500
6% Second Priority Senior Secured Notes	October 2022		400			400
5 ¹/₈% Second Priority Senior Secured Notes	July 2023		700			700
4 ¹/₂% Second Priority Senior Secured Notes	February 2026		500			500
Debt discounts and deferred fees			(36	)		(43	)
Capital leases and other	Various		106			135
Total long-term debt			5,468			5,844
Current portion of long-term debt			(29	)		(38	)
Long-term debt, less current portion		$	5,439		$	5,806

^(a) The Company classifies the term loan as long-term based on our refinancing in July 2019 (see Note 17 for further information).

The Company was in compliance with all debt covenants for all periods presented.

Debt discounts and deferred financing fees are presented net of Long-term debt, less the current portion on the Consolidated Balance Sheets and are amortized to Interest expense, net through maturity.

Revolving Line of Credit

In May 2019, the Company amended and extended its existing revolving line of credit from total capacity of $750 million maturing in May 2020 to $850 million maturing in May 2024.

During fiscal 2019, the Company has made $383 million of repayments on long-term borrowings using existing liquidity.

Financial Instruments and Fair Value Measurements

9 Months Ended

Jun. 29, 2019

Financial Instruments and Fair Value Measurements [Abstract]

Financial Instruments and Fair Value Measurements

9. Financial Instruments and Fair Value Measurements

In the normal course of business, the Company is exposed to certain risks arising from business operations and economic factors. The Company may use derivative financial instruments to help manage market risk and reduce the exposure to fluctuations in interest rates and foreign currencies. These financial instruments are not used for trading or other speculative purposes. For those derivative instruments that are designated and qualify as hedging instruments, the Company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.

To the extent hedging relationships are found to be effective, as determined by FASB guidance, changes in the fair value of the derivatives are offset by changes in the fair value of the related hedged item and recorded to Accumulated other comprehensive loss. Any identified ineffectiveness, or changes in the fair value of a derivative not designated as a hedge, is recorded to the Consolidated Statements of Income.

Cross-Currency Swaps

The Company is party to certain cross-currency swap agreements with a notional amount of €250 million to effectively convert a portion of our fixed-rate U.S. dollar denominated term loans, including the monthly interest payments, to fixed-rate euro-denominated debt. The swap agreements mature in May 2022. The risk management objective is to manage foreign currency risk relating to net investments in certain European subsidiaries denominated in foreign currencies and reduce the variability in the functional currency cash flows of a portion of the Company’s term loans. Changes in fair value of the derivative instruments are recognized in a component of Accumulated other comprehensive loss, to offset the changes in the values of the net investments being hedged.

In preparation of the July 2019 RPC acquisition, the Company entered into certain foreign exchange forward contracts to partially mitigate the currency exchange rate risk associated with the GBP denominated purchase price. At June 29, 2019, the Company had outstanding forward contracts totaling £2.7 billion. For the quarter ended June 29, 2019, the Company recognized an unrealized loss of $120 million in Other expense, net in the Consolidated Statement of Income associated with the forward contracts.

The primary purpose of the Company’s interest rate swap activities is to manage cash flow variability associated with our outstanding variable rate term loan debt.

During fiscal 2017, the Company modified various term loan rates and maturities. In conjunction with these modifications the Company realigned existing swap agreements which resulted in the de-designation of the original hedge and re-designation of the modified swaps as effective cash flow hedges. The amounts included in Accumulated other comprehensive loss at the date of de-designation are being amortized to Interest expense through the terms of the original swaps.

As of June 29, 2019, the Company effectively had (i) a $450 million interest rate swap transaction that swaps a one month variable LIBOR contract for a fixed annual rate of 2.000%, with an effective date in May 2017 and expiration in May 2022, (ii) a $1 billion interest rate swap transaction that swaps a one month variable LIBOR contract for a fixed annual rate of 2.808% with an effective date in June 2018 and expiration in September 2021, (iii) a $400 million interest rate swap transaction that swaps a one month variable LIBOR contract for a fixed annual rate of 2.533% with an effective date in February 2019 and expiration in July 2023, (iv) a $884 million interest rate swap transaction that swaps a one month variable LIBOR contract plus 250 basis point spread for a fixed annual rate of 4.357%, with an effective date in July 2019 and expiration in June 2024, and (v) a $473 million interest rate swap transaction that swaps a one month variable LIBOR contract plus 250 basis point spread for a fixed annual rate of 4.550%, with an effective date in July 2019 and expiration in June 2024.

The Company records the fair value positions of all derivative financial instruments on a net basis by counterparty for which a master netting arrangement is utilized. The categorization of the framework used to value the instruments is considered Level 2, due to the analysis that incorporates observable market inputs including foreign currency spot and forward rates, various interest rate curves, and obtained from pricing data quoted by various banks, third party sources and foreign currency dealers. Balances on a gross basis are as follows:

Derivatives Instruments	Hedge Designation	Balance Sheet Location	June 29, 2019		September 29, 2018
Cross-currency swaps	Designated	Other assets	$	4	$	—
Cross-currency swaps	Designated	Other long-term liabilities		—		11
Cross-currency swaps	Not designated	Other long-term liabilities		18		—
Interest rate swaps	Designated	Other assets		—		16
Interest rate swaps	Designated	Other long-term liabilities		61		—
Interest rate swaps	Not designated	Other long-term liabilities		—		1
Foreign exchange forward contracts	Not designated	Other current liabilities		138		—

		Quarterly Period Ended						Three Quarterly Periods Ended
Derivative Instruments	Statements of Income Location	June 29, 2019			June 30, 2018			June 29, 2019			June 30, 2018
Cross-currency swaps ^(a)	Interest expense, net	$	(2	)	$	(2	)	$	(5	)	$	(4	)
Cross-currency swaps ^(b)	Other expense, net		18			—			18			—
Foreign exchange forward contracts	Other expense, net		120			—			138			—
Interest rate swaps	Interest expense, net		(4	)		(1	)		(13	)		2

^(a) Designated ^(b) Not designated

The amortization related to unrealized losses in Accumulated other comprehensive loss is expected to be $5 million in the next 12 months.

Non-recurring Fair Value Measurements

The Company has certain assets that are measured at fair value on a non-recurring basis when impairment indicators are present or when the Company completes an acquisition. The Company adjusts certain long-lived assets to fair value only when the carrying values exceed the fair values. The categorization of the framework used to value the assets is considered Level 3, due to the subjective nature of the unobservable inputs used to determine the fair value. These assets that are subject to our annual impairment analysis primarily include our definite lived and indefinite lived intangible assets, including Goodwill and our property, plant and equipment. The Company reviews Goodwill and other indefinite lived assets for impairment as of the first day of the fourth fiscal quarter each year and more frequently if impairment indicators exist. The Company determined Goodwill and other indefinite lived assets were not impaired in our annual fiscal 2018 assessment. No impairment indicators were identified in the current quarter.

Included in the following table are the major categories of assets measured at fair value on a non-recurring basis as of June 29, 2019 and September 29, 2018, along with the impairment loss recognized on the fair value measurement during the period:

	As of June 29, 2019
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,911		2,911		—
Definite lived intangible assets		—		—		956		956		—
Property, plant, and equipment		—		—		2,451		2,451		7
Total	$	—	$	—	$	6,566	$	6,566	$	7

	As of September 29, 2018
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,944		2,944		—
Definite lived intangible assets		—		—		1,092		1,092		—
Property, plant, and equipment		—		—		2,488		2,488		—
Total	$	—	$	—	$	6,772	$	6,772	$	—

The Company's financial instruments consist primarily of cash and cash equivalents, long-term debt, interest rate and cross-currency swap agreements, foreign exchange forward contracts, and capital lease obligations. The fair value of our marketable long-term indebtedness exceeded book value by $29 million as of June 29, 2019. The Company's long-term debt fair values were determined using Level 2 inputs as other significant observable inputs were not available.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Income Taxes	9 Months Ended
Income Taxes	Jun. 29, 2019
Income Taxes [Abstract]
Income Taxes	10. Income Taxes In December 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Act”). The transitional impacts of the Tax Act resulted in a transition benefit of $95 million in the nine month period ended June 30, 2018. During the quarter, the Company recorded a $120 million loss on foreign exchange forward contracts related to the acquisition of RPC resulting in a $30 million tax benefit. After excluding the foreign exchange forward contract loss, the effective tax rate would be 19% for the quarter and was positively impacted by a 6% reduction in share-based compensation excess tax benefit deduction and a 3% benefit from the research and development credit. These favorable items were offset by increases of 3% from U.S. State income taxes, 1% from foreign valuation allowance, 3% from the annual GILTI inclusion and other discrete items. The income tax expense decrease of $41 million from the Prior Quarter was primarily attributed to lower pre-tax book income. During the quarter, the Company recorded a $120 million loss on foreign exchange forward contracts related to the acquisition of RPC resulting in a $30 million tax benefit. After excluding the foreign exchange forward contract loss, the effective tax rate would be 19% for the quarter and was positively impacted by a 6% reduction in share-based compensation excess tax benefit deduction and a 3% benefit from the research and development credit. These favorable items were offset by increases of 3% from U.S. State income taxes, 1% from foreign valuation allowance, 3% from the annual GILTI inclusion and other discrete items.

Operating Segments

9 Months Ended

Jun. 29, 2019

Operating Segments [Abstract]

Operating Segments

11. Operating Segments

The Company's operations are organized into three operating segments: Engineered Materials, Health, Hygiene & Specialties, and Consumer Packaging. The structure is designed to align us with our customers, provide optimal service, and drive future growth in a cost efficient manner. Selected information by reportable segment is presented in the following tables:

	Quarterly Period Ended				Three Quarterly Periods Ended
	June 29, 2019		June 30, 2018		June 29, 2019		June 30, 2018
Net sales:
Engineered Materials	$	639	$	687	$	1,936	$	1,990
Health, Hygiene & Specialties		646		726		2,031		2,009
Consumer Packaging		652		659		1,892		1,816
Total net sales	$	1,937	$	2,072	$	5,859	$	5,815
Operating income:
Engineered Materials	$	83	$	94	$	251	$	276
Health, Hygiene & Specialties		65		62		171		140
Consumer Packaging		67		60		154		151
Total operating income	$	215	$	216	$	576	$	567
Depreciation and amortization:
Engineered Materials	$	28	$	26	$	88	$	82
Health, Hygiene & Specialties		49		51		153		146
Consumer Packaging		50		59		156		169
Total depreciation and amortization	$	127	$	136	$	397	$	397

	June 29, 2019		September 29, 2018
Total assets:
Engineered Materials	$	1,931	$	1,998
Health, Hygiene & Specialties		3,738		3,913
Consumer Packaging		3,140		3,220
Total assets	$	8,809	$	9,131

Total goodwill:
Engineered Materials	$	641	$	632
Health, Hygiene & Specialties		861		902
Consumer Packaging		1,409		1,410
Total goodwill	$	2,911	$	2,944

Selected information by geography is presented in the following tables:

	Quarterly Period Ended				Three Quarterly Periods Ended
	June 29, 2019		June 30, 2018		June 29, 2019		June 30, 2018
Net sales:
North America	$	1,591	$	1,759	$	4,791	$	4,835
South America		87		70		271		215
Europe		200		181		614		577
Asia		59		62		183		188
Total net sales	$	1,937	$	2,072	$	5,859	$	5,815

	June 29, 2019		September 29, 2018
Long-lived assets:
North America	$	5,611	$	5,764
South America		328		320
Europe		380		463
Asia		311		299
Total Long-lived assets	$	6,630	$	6,846

Selected information by product line is presented in the following tables:

	Quarterly Period Ended						Three Quarterly Periods Ended
	June 29, 2019			June 30, 2018			June 29, 2019			June 30, 2018
Net sales:
Performance Materials		40			41			39			41
Engineered Products		60			59			61			59
Engineered Materials		100	%		100	%		100	%		100	%

Health		18			18			18			17
Hygiene		49			50			51			51
Specialties		33			32			31			32
Health, Hygiene & Specialties		100	%		100	%		100	%		100	%

Rigid Open Top		47			45			45			43
Rigid Closed Top		53			55			55			57
Consumer Packaging		100	%		100	%		100	%		100	%

Contingencies and Commitments	9 Months Ended
Contingencies and Commitments	Jun. 29, 2019
Contingencies and Commitments [Abstract]
Contingencies and Commitments	12. Contingencies and Commitments The Company is party to various legal proceedings involving routine claims which are incidental to its business. Although the Company's legal and financial liability with respect to such proceedings cannot be estimated with certainty, management believes that any ultimate liability would not be material to its financial statements. The Company has various purchase commitments for raw materials, supplies, and property and equipment incidental to the ordinary conduct of business.

Share Repurchase Program	9 Months Ended
Share Repurchase Program	Jun. 29, 2019
Share Repurchase Program [Abstract]
Share Repurchase Program	13. Share Repurchase Program In fiscal 2018, the Company announced a $500 million share repurchase program. Berry may repurchase shares through the open market, privately negotiated transactions, or other programs, subject to market conditions. This authorization has no expiration date and may be suspended at any time. During the quarterly period ended June 29, 2019, the Company did not repurchase any shares. For the three quarterly periods ended June 29, 2019, the Company repurchased approximately 1,512 thousand shares for $72 million. As of June 29, 2019, $393 million of authorized share repurchases remain available to the Company.

Basic and Diluted Net Income Per Share

9 Months Ended

Jun. 29, 2019

Basic and Diluted Net Income Per Share [Abstract]

Basic and Diluted Net Income Per Share

14. Basic and Diluted Net Income Per Share

Basic net income per share is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for common stock equivalents. Diluted net income per share is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common share equivalents outstanding for the period determined using the treasury-stock method and the if-converted method. For purposes of this calculation, stock options are considered to be common stock equivalents and are only included in the calculation of diluted net income per share when their effect is dilutive. For the three and nine months ended June 29, 2019, 1 million and 2 million shares, respectively, were excluded from the diluted net income per share calculation as their effect would be anti-dilutive.

The following tables provide a reconciliation of the numerator and denominator of the basic and diluted net income per share calculations.

	Quarterly Period Ended				Three Quarterly Periods Ended
(in millions, except per share amounts)	June 29, 2019		June 30, 2018		June 29, 2019		June 30, 2018
Numerator
Net income	$	13	$	110	$	175	$	363
Denominator
Weighted average common shares outstanding - basic		131.5		131.7		131.0		131.3
Dilutive shares		2.7		3.7		3.0		4.5
Weighted average common and common equivalent shares outstanding - diluted		134.2		135.4		134.0		135.8

Per common share income
Basic	$	0.10	$	0.84	$	1.34	$	2.76
Diluted	$	0.10	$	0.81	$	1.31	$	2.67

Accumulated Other Comprehensive Loss

9 Months Ended

Jun. 29, 2019

Accumulated Other Comprehensive Loss [Abstract]

Accumulated Other Comprehensive Loss

15. Accumulated Other Comprehensive Loss

The components and activity of Accumulated other comprehensive loss are as follows:

Quarterly Period Ended	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at March 30, 2019	$	(173	)	$	(13	)	$	—		$	(186	)
Other comprehensive income (loss) before reclassifications		10			—			(44	)		(34	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			(3	)		(3	)
Provision for income taxes		—			—			12			12
Balance at June 29, 2019	$	(163	)	$	(13	)	$	(35	)	$	(211	)

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at March 31, 2018	$	(65	)	$	(17	)	$	26		$	(56	)
Other comprehensive income (loss) before reclassifications		(92	)		—			7			(85	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			(1	)		(1	)
Provision for income taxes		—			—			(2	)		(2	)
Balance at June 30, 2018	$	(157	)	$	(17	)	$	30		$	(144	)

Three Quarterly Periods Ended	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at September 29, 2018	$	(175	)	$	(13	)	$	32		$	(156	)
Other comprehensive income (loss) before reclassifications		12			—			(82	)		(70	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			(8	)		(8	)
Provision for income taxes		—			—			23			23
Balance at June 29, 2019	$	(163	)	$	(13	)	$	(35	)	$	(211	)

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at September 30, 2017	$	(48	)	$	(16	)	$	(4	)	$	(68	)
Other comprehensive income (loss) before reclassifications		(109	)		(1	)		42			(68	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			5			5
Provision for income taxes		—			—			(13	)		(13	)
Balance at June 30, 2018	$	(157	)	$	(17	)	$	30		$	(144	)

Guarantor and Non-Guarantor Financial Information

9 Months Ended

Jun. 29, 2019

Guarantor and Non-Guarantor Financial Information [Abstract]

Guarantor and Non-Guarantor Financial Information

16. Guarantor and Non-Guarantor Financial Information

Berry Global, Inc. (“Issuer”) has notes outstanding which are fully, jointly, severally, and unconditionally guaranteed by its parent, Berry Global Group, Inc. (for purposes of this Note, “Parent”) and substantially all of Issuer’s domestic subsidiaries. Separate narrative information or financial statements of the guarantor subsidiaries have not been included because they are 100% owned by Parent and the guarantor subsidiaries unconditionally guarantee such debt on a joint and several basis. A guarantee of a guarantor subsidiary of the securities will terminate upon the following customary circumstances: the sale of the capital stock of such guarantor if such sale complies with the indentures, the designation of such guarantor as an unrestricted subsidiary, the defeasance or discharge of the indenture or in the case of a restricted subsidiary that is required to guarantee after the relevant issuance date, if such guarantor no longer guarantees certain other indebtedness of the issuer. The guarantees of the guarantor subsidiaries are also limited as necessary to prevent them from constituting a fraudulent conveyance under applicable law and any guarantees guaranteeing subordinated debt are subordinated to certain other of the Company’s debts. Parent also guarantees the Issuer’s term loans and revolving credit facilities. The guarantor subsidiaries guarantee our term loans and are co-borrowers under our revolving credit facility. Presented below is condensed consolidating financial information for the Parent, Issuer, guarantor subsidiaries and non-guarantor subsidiaries. The Issuer and guarantor financial information includes all of our domestic operating subsidiaries; our non-guarantor subsidiaries include our foreign subsidiaries, certain immaterial domestic subsidiaries and the unrestricted subsidiaries under the Issuer’s indentures. The Parent uses the equity method to account for its ownership in the Issuer in the Condensed Consolidating Supplemental Financial Statements. The Issuer uses the equity method to account for its ownership in the guarantor and non-guarantor subsidiaries. All consolidating entries are included in the eliminations column along with the elimination of intercompany balances.

Condensed Supplemental Consolidated Balance Sheet

	June 29, 2019
	Parent		Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations			Total
Current assets	$	—	$	203	$	1,160	$	816	$	—		$	2,179
Intercompany receivable		203		1,762		—		24		(1,989	)		—
Property, plant, and equipment, net		—		80		1,655		716		—			2,451
Other assets		1,688		6,402		4,740		426		(9,077	)		4,179
Total assets	$	1,891	$	8,447	$	7,555	$	1,982	$	(11,066	)	$	8,809

Current liabilities	$	12	$	356	$	513	$	275	$	—		$	1,156
Intercompany payable		—		—		1,989		—		(1,989	)		—
Other long-term liabilities		333		5,650		57		67		—			6,107
Stockholders' equity		1,546		2,441		4,996		1,640		(9,077	)		1,546
Total liabilities and stockholders' equity	$	1,891	$	8,447	$	7,555	$	1,982	$	(11,066	)	$	8,809

	September 29, 2018
	Parent		Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations			Total
Current assets	$	—	$	249	$	1,240	$	796	$	—		$	2,285
Intercompany receivable		296		1,907		—		49		(2,252	)		—
Property, plant and equipment, net		—		79		1,684		725		—			2,488
Other assets		1,544		6,247		4,849		487		(8,769	)		4,358
Total assets	$	1,840	$	8,482	$	7,773	$	2,057	$	(11,021	)	$	9,131

Current liabilities	$	18	$	218	$	635	$	366	$	—		$	1,237
Intercompany payable		—		—		2,252		—		(2,252	)		—
Other long-term liabilities		388		5,945		68		59		—			6,460
Stockholders' equity		1,434		2,319		4,818		1,632		(8,769	)		1,434
Total liabilities and stockholders' equity	$	1,840	$	8,482	$	7,773	$	2,057	$	(11,021	)	$	9,131

Condensed Supplemental Consolidated Statements of Income

	Quarterly Period Ended June 29, 2019
	Parent			Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations			Total
Net sales	$	—		$	139		$	1,358	$	440	$	—		$	1,937
Cost of goods sold		—			43			1,139		375		—			1,557
Selling, general and administrative		—			13			84		28		—			125
Amortization of intangibles		—			—			33		5		—			38
Restructuring and impairment charges		—			—			1		1		—			2
Operating income		—			83			101		31		—			215
Other expense (income), net		—			135			—		1		—			136
Interest expense, net		—			5			51		15		—			71
Equity in net income of subsidiaries		(8	)		(51	)		—		—		59			—
Income before income taxes		8			(6	)		50		15		(59	)		8
Income tax expense		(5	)		(19	)		—		14		5			(5	)
Net income	$	13		$	13		$	50	$	1	$	(64	)	$	13
Comprehensive net income	$	13		$	(24	)	$	50	$	13	$	(64	)	$	(12	)

	Quarterly Period Ended June 30, 2018
	Parent			Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	147		$	1,452	$	473		$	—		$	2,072
Cost of goods sold		—			121			1,173		396			—			1,690
Selling, general and administrative		—			14			70		35			—			119
Amortization of intangibles		—			—			34		6			—			40
Restructuring and impairment charges		—			—			4		3			—			7
Operating income (loss)		—			12			171		33			—			216
Other income, net		—			—			1		2			—			3
Interest expense, net		—			5			46		16			—			67
Equity in net income of subsidiaries		(146	)		(128	)		—		—			274			—
Income before income taxes		146			135			124		15			(274	)		146
Income tax expense		36			25			3		8			(36	)		36
Net income	$	110		$	110		$	121	$	7		$	(238	)	$	110
Comprehensive net income	$	110		$	133		$	121	$	(104	)	$	(238	)	$	22

	Three Quarterly Periods Ended June 29, 2019
	Parent			Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations			Total
Net sales	$	—		$	417		$	4,097	$	1,345	$	—		$	5,859
Cost of goods sold		—			204			3,403		1,147		—			4,754
Selling, general and administrative		—			50			259		83		—			392
Amortization of intangibles		—			—			102		17		—			119
Restructuring and impairment charges		—			—			11		7		—			18
Operating income		—			163			322		91		—			576
Other expense (income), net		—			154			2		3		—			159
Interest expense, net		—			14			142		45		—			201
Equity in net income of subsidiaries		(216	)		(188	)		—		—		404			—
Income before income taxes		216			183			178		43		(404	)		216
Income tax expense		41			8			—		33		(41	)		41
Net income	$	175		$	175		$	178	$	10	$	(363	)	$	175
Comprehensive net income	$	175		$	122		$	178	$	8	$	(363	)	$	120

	Three Quarterly Periods Ended June 30, 2018
	Parent			Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	424		$	4,026	$	1,365		$	—		$	5,815
Cost of goods sold		—			322			3,265		1,146			—			4,733
Selling, general and administrative		—			44			233		89			—			366
Amortization of intangibles		—			—			96		20			—			116
Restructuring and impairment charges		—			—			20		13			—			33
Operating income		—			58			412		97			—			567
Other expense (income), net		—			5			8		4			—			17
Interest expense, net		—			14			134		47			—			195
Equity in net income of subsidiaries		(355	)		(287	)		—		—			642			—
Income before income taxes		355			326			270		46			(642	)		355
Income tax expense		(8	)		(37	)		4		25			8			(8	)
Net income	$	363		$	363		$	266	$	21		$	(650	)	$	363
Comprehensive net income	$	363		$	387		$	266	$	(79	)	$	(650	)	$	287

Condensed Supplemental Consolidated Statements of Cash Flows

	Three Quarterly Periods Ended June 29, 2019
	Parent			Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Total
Cash Flow from Operating Activities	$	—		$	109		$	448		$	14		$	—		$	571
Cash Flow from Investing Activities
Additions to property, plant, and equipment		—			—			(180	)		(91	)		—			(271	)
Proceeds from sale of assets		—			—			—			—			—			—
(Contributions) distributions to/from subsidiaries		31			(31	)		—			—			—			—
Intercompany advances (repayments)		—			193			—			—			(193	)		—
Acquisition of business, net of cash acquired		—			—			2			—			—			2
Net cash from investing activities		31			162			(178	)		(91	)		(193	)		(269	)

Cash Flow from Financing Activities
Repayments on long-term borrowings		—			(377	)		(5	)		(1	)		—			(383	)
Proceeds from issuance of common stock		43			—			—			—			—			43
Repurchase of common stock		(74	)		—			—			—			—			(74	)
Payment of tax receivable agreement		(16	)		—			—			—			—			(16	)
Changes in intercompany balances		16			—			(267	)		58			193			—
Net cash from financing activities		(31	)		(377	)		(272	)		57			193			(430	)

Effect of exchange rate changes on cash		—			—			—			2			—			2

Net change in cash		—			(106	)		(2	)		(18	)		—			(126	)
Cash and cash equivalents at beginning of period		—			133			4			244			—			381
Cash and cash equivalents at end of period	$	—		$	27		$	2		$	226		$	—		$	255

	Three Quarterly Periods Ended June 30, 2018
	Parent			Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Total
Cash Flow from Operating Activities	$	—		$	29		$	480		$	47		$	—		$	556
Cash Flow from Investing Activities
Additions to property, plant, and equipment		—			(5	)		(194	)		(71	)		—			(270	)
Proceeds from sale of assets		—			—			—			3			—			3
(Contributions) distributions to/from subsidiaries		(17	)		(457	)		—			—			474			—
Intercompany advances (repayments)		—			314			—			—			(314	)		—
Acquisition of business, net of cash acquired		—			—			(404	)		(70	)		—			(474	)
Net cash from investing activities		(17	)		(148	)		(598	)		(138	)		160			(741	)

Cash Flow from Financing Activities
Proceeds from long-term borrowings		—			497			—			—			—			497
Repayments on long-term borrowings		—			(219	)		(5	)		—			—			(224	)
Proceeds from issuance of common stock		17			—			—			—			—			17
Payment of tax receivable agreement		(37	)		—			—			—			—			(37	)
Contribution from Parent		—			—			404			70			(474	)		—
Debt financing costs		—			(1	)		—			—			—			(1	)
Changes in intercompany balances		37			—			(291	)		(60	)		314			—
Net cash from financing activities		17			277			108			10			(160	)		252

Effect of exchange rate changes on cash		—			—			—			(8	)		—			(8	)

Net change in cash		—			158			(10	)		(89	)		—			59
Cash and cash equivalents at beginning of period		—			18			12			276			—			306
Cash and cash equivalents at end of period	$	—		$	176		$	13		$	187		$	—		$	365

Subsequent Events	9 Months Ended
Subsequent Events	Jun. 29, 2019
Subsequent Events [Abstract]
Subsequent Events	17. Subsequent Events RPC Group Plc In July 2019, the Company completed the acquisition of the entire outstanding share capital of RPC Group Plc (“RPC”), for aggregate consideration of approximately $6.5 billion (including refinancing of RPC’s net debt), which is preliminary and subject to adjustment. RPC is a leading plastic product design and engineering company for packaging and selected non-packaging markets,with 189 sites in 34 countries. RPC develops and manufactures a diverse range of products for a wide variety of customers, including many household names, and enjoys strong market positions in many of the end-markets it serves and the geographical areas in which it operates. It uses a wide range of polymer conversion techniques in both rigid and flexible plastics manufacture, and is now one of the largest plastic converters in Europe, combining both the development of innovative packaging and technical solutions for its customers with good levels of service and support. The acquired business will be primarily operated in a new Consumer Packaging International reporting segment. To finance the all-cash purchase, the Company issued $1,250 million aggregate principal amount of 4.875% first priority senior secured notes due 2026, $500 million aggregate principal amount of 5.625% second priority senior secured notes due 2027, and entered into an incremental assumption agreement to provide incremental $4,250 million and €1,075 million term loans, due July 2026. Additionally, proceeds of the term loan were used to refinance the Company's existing $450 million term loan due February 2020. The acquisition will be accounted for under the purchase method of accounting and the purchase price will be allocated to the identifiable assets and liabilities. Given the timing of the acquisition, a preliminary purchase price allocation is not yet available. Unaudited, estimated pro forma net sales and net income was approximately $12.9 billion and $530 million, respectively, for fiscal 2018. The unaudited pro forma net sales and net income assume that the RPC acquisition had occurred as of the beginning of the respective period. This unaudited pro forma information provided is preliminary and subject to change, for informational purposes only and is not necessarily indicative of the operating results that would have occurred had the RPC acquisition been consummated at the beginning of the respective period, nor is it necessarily indicative of future operating results. Seal For Life In July 2019, the Company completed the sale of its Seal For Life ("SFL") business within our Health, Hygiene & Specialties reporting segment for total proceeds of approximately $330 million, which is preliminary and subject to adjustment. The SFL business has annual sales of approximately $120 million. For the period ended June 29, 2019, the Company has classified assets of $108 million and liabilities of $21 million as held for sale. We are in the process of evaluating the transaction and its impact on our financial statements and expect to record a gain in Other expense, net in the Consolidated Statements of Income.

Basis of Presentation (Policies)	9 Months Ended
Basis of Presentation (Policies)	Jun. 29, 2019
Basis of Presentation [Abstract]
Basis of Presentation	The accompanying unaudited Condensed Consolidated Financial Statements of Berry Global Group, Inc. ("the Company," "we," or "Berry") have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") pursuant to the rules and regulations of the Securities and Exchange Commission for interim reporting. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.
Use of Estimates	In preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts and disclosures at the date of the financial statements and during the reporting period. Actual results could differ from those estimates.
Reclassifications	Certain reclassifications have been made to prior periods to conform to current reporting.

Recently Issued Accounting Pronouncements (Policies)	9 Months Ended
Recently Issued Accounting Pronouncements (Policies)	Jun. 29, 2019
Recently Issued Accounting Pronouncements [Abstract]
Recently Issued Accounting Pronouncements	Changes to GAAP are established by the Financial Accounting Standards Board ("FASB") in the form of accounting standards updates to the FASB's Accounting Standards Codification. During fiscal 2019, with the exception of the below, there have been no developments to the recently adopted accounting pronouncements from those disclosed in the Company's 2018 Annual Report on Form 10-K that are considered to have a material impact on our unaudited consolidated financial statements. Revenue Recognition In May 2014, the FASB issued a final standard on revenue recognition. Under the new standard, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. For public entities, the provisions of the new standard are effective for annual reporting periods beginning after December 15, 2017 and interim periods therein. An entity can apply the new revenue standard on a full retrospective approach to each prior reporting period presented or on a modified retrospective approach with the cumulative effect of initially applying the standard recognized at the date of initial application in retained earnings. The Company adopted the new standard effective for fiscal 2019 using the modified retrospective approach. The adoption of this standard did not have a material impact on the Company's consolidated financial statements. Leases In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which increases transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. Under the new standard, the lessee of an operating lease will be required to do the following: 1) recognize a right-of-use asset and a lease liability in the statement of financial position, 2) recognize a single lease cost allocated over the lease term generally on a straight-line basis, and 3) classify all cash payments within operating activities on the statement of cash flows. Companies are required to adopt this standard using a modified retrospective transition method. Amendments in this standard are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company has made substantial progress analyzing its lease contracts and has developed business processes and internal controls in preparation for the new standard. We are currently evaluating the financial statement impact to the Company as well as the expanded disclosure requirements. The new standard will be effective for the Company beginning fiscal 2020. Credit Losses In June 2016, the FASB issued 2016-13, Financial Instruments - Credit Losses (Topic 326) and issued subsequent amendments to the initial guidance. The new standard requires entities to measure all expected credit losses for most financial assets held at the reporting date based on an expected loss model, which includes historical experience, current conditions, and reasonable and supportable forecasts. The new standard also requires enhanced disclosure. The new standard is effective for interim and annual periods beginning after December 15, 2019. The Company is in the process of evaluating this new standard, however, the Company does not anticipate this to have a material impact.

Acquisitions (Tables)

9 Months Ended

Jun. 29, 2019

Purchase Price Allocation

The following table summarizes the purchase price allocation and estimated fair values of the assets acquired and liabilities assumed at the date of the acquisition:

Working capital ^(a)	$	70
Property and equipment		164
Intangible assets		125
Goodwill		111
Other assets and long-term liabilities		5

^(a) Includes a $3 million step up of inventory to fair value

Restructuring and Impairment Charges (Tables)

9 Months Ended

Jun. 29, 2019

Restructuring and Impairment Charges [Abstract]

Restructuring Charges by Segment

The tables below set forth the significant components of the restructuring charges recognized, by segment:

	Quarterly Period Ended				Three Quarterly Periods Ended
	June 29, 2019		June 30, 2018		June 29, 2019		June 30, 2018
Engineered Materials	$	—	$	2	$	1	$	4
Health, Hygiene & Specialties		1		4		13		26
Consumer Packaging		1		1		4		3
Consolidated	$	2	$	7	$	18	$	33

Restructuring Accrual Activity

The table below sets forth the activity with respect to the restructuring accrual at June 29, 2019:

	Employee Severance and Benefits			Facility Exit Costs			Non-cash Impairment Charges			Total
Balance at September 29, 2018	$	9		$	4		$	—		$	13
Charges		7			4			7			18
Non-cash asset impairment		—			—			(7	)		(7	)
Cash payments		(13	)		(3	)		—			(16	)
Balance at June 29, 2019	$	3		$	5		$	—		$	8

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities (Tables)

9 Months Ended

Jun. 29, 2019

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]

Accrued Expenses and Other Current Liabilities

The following table sets forth the totals included in Accrued expenses and other current liabilities on the Consolidated Balance Sheets:

	June 29, 2019		September 29, 2018
Derivative instruments	$	138	$	—
Employee compensation		99		113
Accrued taxes		66		72
Rebates		60		58
Interest		41		49
Tax receivable agreement obligation		12		16
Restructuring		8		13
Accrued operating expenses		98		95
	$	522	$	416

Other Long-Term Liabilities

The following table sets forth the totals included in Other long-term liabilities on the Consolidated Balance Sheets:

	June 29, 2019		September 29, 2018
Derivative instruments	$	79	$	12
Uncertain tax positions		67		67
Deferred purchase price		45		40
Pension liability		42		45
Lease retirement obligation		41		39
Sale-lease back deferred gain		20		21
Transition tax		17		18
Tax receivable agreement obligation		10		23
Other		24		24
	$	345	$	289

Long-Term Debt (Tables)

9 Months Ended

Jun. 29, 2019

Long-Term Debt [Abstract]

Long-Term Debt

Long-term debt consists of the following:

Facility	Maturity Date	June 29, 2019			September 29, 2018
Term loan	February 2020 ^(a)	$	450		$	800
Term loan	January 2021		814			814
Term loan	October 2022		1,545			1,545
Term loan	January 2024		489			493
Revolving line of credit	May 2024		—			—
5 ¹/₂% Second Priority Senior Secured Notes	May 2022		500			500
6% Second Priority Senior Secured Notes	October 2022		400			400
5 ¹/₈% Second Priority Senior Secured Notes	July 2023		700			700
4 ¹/₂% Second Priority Senior Secured Notes	February 2026		500			500
Debt discounts and deferred fees			(36	)		(43	)
Capital leases and other	Various		106			135
Total long-term debt			5,468			5,844
Current portion of long-term debt			(29	)		(38	)
Long-term debt, less current portion		$	5,439		$	5,806

^(a) The Company classifies the term loan as long-term based on our refinancing in July 2019 (see Note 17 for further information).

Financial Instruments and Fair Value Measurements (Tables)

9 Months Ended

Jun. 29, 2019

Financial Instruments and Fair Value Measurements [Abstract]

Fair Value of Derivatives and Location on Consolidated Balance Sheets

Derivatives Instruments	Hedge Designation	Balance Sheet Location	June 29, 2019		September 29, 2018
Cross-currency swaps	Designated	Other assets	$	4	$	—
Cross-currency swaps	Designated	Other long-term liabilities		—		11
Cross-currency swaps	Not designated	Other long-term liabilities		18		—
Interest rate swaps	Designated	Other assets		—		16
Interest rate swaps	Designated	Other long-term liabilities		61		—
Interest rate swaps	Not designated	Other long-term liabilities		—		1
Foreign exchange forward contracts	Not designated	Other current liabilities		138		—

Effect of Derivatives on Consolidated Statements of Income

The effect of the Company's derivative instruments on the Consolidated Statements of Income is as follows:

		Quarterly Period Ended						Three Quarterly Periods Ended
Derivative Instruments	Statements of Income Location	June 29, 2019			June 30, 2018			June 29, 2019			June 30, 2018
Cross-currency swaps ^(a)	Interest expense, net	$	(2	)	$	(2	)	$	(5	)	$	(4	)
Cross-currency swaps ^(b)	Other expense, net		18			—			18			—
Foreign exchange forward contracts	Other expense, net		120			—			138			—
Interest rate swaps	Interest expense, net		(4	)		(1	)		(13	)		2

Assets Measured at Fair Value on Non-recurring Basis

	As of June 29, 2019
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,911		2,911		—
Definite lived intangible assets		—		—		956		956		—
Property, plant, and equipment		—		—		2,451		2,451		7
Total	$	—	$	—	$	6,566	$	6,566	$	7

	As of September 29, 2018
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,944		2,944		—
Definite lived intangible assets		—		—		1,092		1,092		—
Property, plant, and equipment		—		—		2,488		2,488		—
Total	$	—	$	—	$	6,772	$	6,772	$	—

Operating Segments (Tables)

9 Months Ended

Jun. 29, 2019

Operating Segments [Abstract]

Selected Information by Reportable Segment

	Quarterly Period Ended				Three Quarterly Periods Ended
	June 29, 2019		June 30, 2018		June 29, 2019		June 30, 2018
Net sales:
Engineered Materials	$	639	$	687	$	1,936	$	1,990
Health, Hygiene & Specialties		646		726		2,031		2,009
Consumer Packaging		652		659		1,892		1,816
Total net sales	$	1,937	$	2,072	$	5,859	$	5,815
Operating income:
Engineered Materials	$	83	$	94	$	251	$	276
Health, Hygiene & Specialties		65		62		171		140
Consumer Packaging		67		60		154		151
Total operating income	$	215	$	216	$	576	$	567
Depreciation and amortization:
Engineered Materials	$	28	$	26	$	88	$	82
Health, Hygiene & Specialties		49		51		153		146
Consumer Packaging		50		59		156		169
Total depreciation and amortization	$	127	$	136	$	397	$	397

	June 29, 2019		September 29, 2018
Total assets:
Engineered Materials	$	1,931	$	1,998
Health, Hygiene & Specialties		3,738		3,913
Consumer Packaging		3,140		3,220
Total assets	$	8,809	$	9,131

Total goodwill:
Engineered Materials	$	641	$	632
Health, Hygiene & Specialties		861		902
Consumer Packaging		1,409		1,410
Total goodwill	$	2,911	$	2,944

Selected Information by Geography

Selected information by geography is presented in the following tables:

	Quarterly Period Ended				Three Quarterly Periods Ended
	June 29, 2019		June 30, 2018		June 29, 2019		June 30, 2018
Net sales:
North America	$	1,591	$	1,759	$	4,791	$	4,835
South America		87		70		271		215
Europe		200		181		614		577
Asia		59		62		183		188
Total net sales	$	1,937	$	2,072	$	5,859	$	5,815

	June 29, 2019		September 29, 2018
Long-lived assets:
North America	$	5,611	$	5,764
South America		328		320
Europe		380		463
Asia		311		299
Total Long-lived assets	$	6,630	$	6,846

Selected Information by Product Line

Selected information by product line is presented in the following tables:

	Quarterly Period Ended						Three Quarterly Periods Ended
	June 29, 2019			June 30, 2018			June 29, 2019			June 30, 2018
Net sales:
Performance Materials		40			41			39			41
Engineered Products		60			59			61			59
Engineered Materials		100	%		100	%		100	%		100	%

Health		18			18			18			17
Hygiene		49			50			51			51
Specialties		33			32			31			32
Health, Hygiene & Specialties		100	%		100	%		100	%		100	%

Rigid Open Top		47			45			45			43
Rigid Closed Top		53			55			55			57
Consumer Packaging		100	%		100	%		100	%		100	%

Basic and Diluted Net Income Per Share (Tables)

9 Months Ended

Jun. 29, 2019

Basic and Diluted Net Income Per Share [Abstract]

Basic and Diluted Net Income Per Share

The following tables provide a reconciliation of the numerator and denominator of the basic and diluted net income per share calculations.

	Quarterly Period Ended				Three Quarterly Periods Ended
(in millions, except per share amounts)	June 29, 2019		June 30, 2018		June 29, 2019		June 30, 2018
Numerator
Net income	$	13	$	110	$	175	$	363
Denominator
Weighted average common shares outstanding - basic		131.5		131.7		131.0		131.3
Dilutive shares		2.7		3.7		3.0		4.5
Weighted average common and common equivalent shares outstanding - diluted		134.2		135.4		134.0		135.8

Per common share income
Basic	$	0.10	$	0.84	$	1.34	$	2.76
Diluted	$	0.10	$	0.81	$	1.31	$	2.67

Accumulated Other Comprehensive Loss (Tables)

9 Months Ended

Jun. 29, 2019

Accumulated Other Comprehensive Loss [Abstract]

Accumulated Other Comprehensive Loss

The components and activity of Accumulated other comprehensive loss are as follows:

Quarterly Period Ended	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at March 30, 2019	$	(173	)	$	(13	)	$	—		$	(186	)
Other comprehensive income (loss) before reclassifications		10			—			(44	)		(34	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			(3	)		(3	)
Provision for income taxes		—			—			12			12
Balance at June 29, 2019	$	(163	)	$	(13	)	$	(35	)	$	(211	)

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at March 31, 2018	$	(65	)	$	(17	)	$	26		$	(56	)
Other comprehensive income (loss) before reclassifications		(92	)		—			7			(85	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			(1	)		(1	)
Provision for income taxes		—			—			(2	)		(2	)
Balance at June 30, 2018	$	(157	)	$	(17	)	$	30		$	(144	)

Three Quarterly Periods Ended	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at September 29, 2018	$	(175	)	$	(13	)	$	32		$	(156	)
Other comprehensive income (loss) before reclassifications		12			—			(82	)		(70	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			(8	)		(8	)
Provision for income taxes		—			—			23			23
Balance at June 29, 2019	$	(163	)	$	(13	)	$	(35	)	$	(211	)

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at September 30, 2017	$	(48	)	$	(16	)	$	(4	)	$	(68	)
Other comprehensive income (loss) before reclassifications		(109	)		(1	)		42			(68	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			5			5
Provision for income taxes		—			—			(13	)		(13	)
Balance at June 30, 2018	$	(157	)	$	(17	)	$	30		$	(144	)

Guarantor and Non-Guarantor Financial Information (Tables)

9 Months Ended

Jun. 29, 2019

Guarantor and Non-Guarantor Financial Information [Abstract]

Condensed Supplemental Consolidated Financial Information

Condensed Supplemental Consolidated Balance Sheet

	June 29, 2019
	Parent		Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations			Total
Current assets	$	—	$	203	$	1,160	$	816	$	—		$	2,179
Intercompany receivable		203		1,762		—		24		(1,989	)		—
Property, plant, and equipment, net		—		80		1,655		716		—			2,451
Other assets		1,688		6,402		4,740		426		(9,077	)		4,179
Total assets	$	1,891	$	8,447	$	7,555	$	1,982	$	(11,066	)	$	8,809

Current liabilities	$	12	$	356	$	513	$	275	$	—		$	1,156
Intercompany payable		—		—		1,989		—		(1,989	)		—
Other long-term liabilities		333		5,650		57		67		—			6,107
Stockholders' equity		1,546		2,441		4,996		1,640		(9,077	)		1,546
Total liabilities and stockholders' equity	$	1,891	$	8,447	$	7,555	$	1,982	$	(11,066	)	$	8,809

	September 29, 2018
	Parent		Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations			Total
Current assets	$	—	$	249	$	1,240	$	796	$	—		$	2,285
Intercompany receivable		296		1,907		—		49		(2,252	)		—
Property, plant and equipment, net		—		79		1,684		725		—			2,488
Other assets		1,544		6,247		4,849		487		(8,769	)		4,358
Total assets	$	1,840	$	8,482	$	7,773	$	2,057	$	(11,021	)	$	9,131

Current liabilities	$	18	$	218	$	635	$	366	$	—		$	1,237
Intercompany payable		—		—		2,252		—		(2,252	)		—
Other long-term liabilities		388		5,945		68		59		—			6,460
Stockholders' equity		1,434		2,319		4,818		1,632		(8,769	)		1,434
Total liabilities and stockholders' equity	$	1,840	$	8,482	$	7,773	$	2,057	$	(11,021	)	$	9,131

Condensed Supplemental Consolidated Statements of Income

	Quarterly Period Ended June 29, 2019
	Parent			Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations			Total
Net sales	$	—		$	139		$	1,358	$	440	$	—		$	1,937
Cost of goods sold		—			43			1,139		375		—			1,557
Selling, general and administrative		—			13			84		28		—			125
Amortization of intangibles		—			—			33		5		—			38
Restructuring and impairment charges		—			—			1		1		—			2
Operating income		—			83			101		31		—			215
Other expense (income), net		—			135			—		1		—			136
Interest expense, net		—			5			51		15		—			71
Equity in net income of subsidiaries		(8	)		(51	)		—		—		59			—
Income before income taxes		8			(6	)		50		15		(59	)		8
Income tax expense		(5	)		(19	)		—		14		5			(5	)
Net income	$	13		$	13		$	50	$	1	$	(64	)	$	13
Comprehensive net income	$	13		$	(24	)	$	50	$	13	$	(64	)	$	(12	)

	Quarterly Period Ended June 30, 2018
	Parent			Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	147		$	1,452	$	473		$	—		$	2,072
Cost of goods sold		—			121			1,173		396			—			1,690
Selling, general and administrative		—			14			70		35			—			119
Amortization of intangibles		—			—			34		6			—			40
Restructuring and impairment charges		—			—			4		3			—			7
Operating income (loss)		—			12			171		33			—			216
Other income, net		—			—			1		2			—			3
Interest expense, net		—			5			46		16			—			67
Equity in net income of subsidiaries		(146	)		(128	)		—		—			274			—
Income before income taxes		146			135			124		15			(274	)		146
Income tax expense		36			25			3		8			(36	)		36
Net income	$	110		$	110		$	121	$	7		$	(238	)	$	110
Comprehensive net income	$	110		$	133		$	121	$	(104	)	$	(238	)	$	22

	Three Quarterly Periods Ended June 29, 2019
	Parent			Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations			Total
Net sales	$	—		$	417		$	4,097	$	1,345	$	—		$	5,859
Cost of goods sold		—			204			3,403		1,147		—			4,754
Selling, general and administrative		—			50			259		83		—			392
Amortization of intangibles		—			—			102		17		—			119
Restructuring and impairment charges		—			—			11		7		—			18
Operating income		—			163			322		91		—			576
Other expense (income), net		—			154			2		3		—			159
Interest expense, net		—			14			142		45		—			201
Equity in net income of subsidiaries		(216	)		(188	)		—		—		404			—
Income before income taxes		216			183			178		43		(404	)		216
Income tax expense		41			8			—		33		(41	)		41
Net income	$	175		$	175		$	178	$	10	$	(363	)	$	175
Comprehensive net income	$	175		$	122		$	178	$	8	$	(363	)	$	120

	Three Quarterly Periods Ended June 30, 2018
	Parent			Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	424		$	4,026	$	1,365		$	—		$	5,815
Cost of goods sold		—			322			3,265		1,146			—			4,733
Selling, general and administrative		—			44			233		89			—			366
Amortization of intangibles		—			—			96		20			—			116
Restructuring and impairment charges		—			—			20		13			—			33
Operating income		—			58			412		97			—			567
Other expense (income), net		—			5			8		4			—			17
Interest expense, net		—			14			134		47			—			195
Equity in net income of subsidiaries		(355	)		(287	)		—		—			642			—
Income before income taxes		355			326			270		46			(642	)		355
Income tax expense		(8	)		(37	)		4		25			8			(8	)
Net income	$	363		$	363		$	266	$	21		$	(650	)	$	363
Comprehensive net income	$	363		$	387		$	266	$	(79	)	$	(650	)	$	287

Condensed Supplemental Consolidated Statements of Cash Flows

	Three Quarterly Periods Ended June 29, 2019
	Parent			Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Total
Cash Flow from Operating Activities	$	—		$	109		$	448		$	14		$	—		$	571
Cash Flow from Investing Activities
Additions to property, plant, and equipment		—			—			(180	)		(91	)		—			(271	)
Proceeds from sale of assets		—			—			—			—			—			—
(Contributions) distributions to/from subsidiaries		31			(31	)		—			—			—			—
Intercompany advances (repayments)		—			193			—			—			(193	)		—
Acquisition of business, net of cash acquired		—			—			2			—			—			2
Net cash from investing activities		31			162			(178	)		(91	)		(193	)		(269	)

Cash Flow from Financing Activities
Repayments on long-term borrowings		—			(377	)		(5	)		(1	)		—			(383	)
Proceeds from issuance of common stock		43			—			—			—			—			43
Repurchase of common stock		(74	)		—			—			—			—			(74	)
Payment of tax receivable agreement		(16	)		—			—			—			—			(16	)
Changes in intercompany balances		16			—			(267	)		58			193			—
Net cash from financing activities		(31	)		(377	)		(272	)		57			193			(430	)

Effect of exchange rate changes on cash		—			—			—			2			—			2

Net change in cash		—			(106	)		(2	)		(18	)		—			(126	)
Cash and cash equivalents at beginning of period		—			133			4			244			—			381
Cash and cash equivalents at end of period	$	—		$	27		$	2		$	226		$	—		$	255

	Three Quarterly Periods Ended June 30, 2018
	Parent			Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Total
Cash Flow from Operating Activities	$	—		$	29		$	480		$	47		$	—		$	556
Cash Flow from Investing Activities
Additions to property, plant, and equipment		—			(5	)		(194	)		(71	)		—			(270	)
Proceeds from sale of assets		—			—			—			3			—			3
(Contributions) distributions to/from subsidiaries		(17	)		(457	)		—			—			474			—
Intercompany advances (repayments)		—			314			—			—			(314	)		—
Acquisition of business, net of cash acquired		—			—			(404	)		(70	)		—			(474	)
Net cash from investing activities		(17	)		(148	)		(598	)		(138	)		160			(741	)

Cash Flow from Financing Activities
Proceeds from long-term borrowings		—			497			—			—			—			497
Repayments on long-term borrowings		—			(219	)		(5	)		—			—			(224	)
Proceeds from issuance of common stock		17			—			—			—			—			17
Payment of tax receivable agreement		(37	)		—			—			—			—			(37	)
Contribution from Parent		—			—			404			70			(474	)		—
Debt financing costs		—			(1	)		—			—			—			(1	)
Changes in intercompany balances		37			—			(291	)		(60	)		314			—
Net cash from financing activities		17			277			108			10			(160	)		252

Effect of exchange rate changes on cash		—			—			—			(8	)		—			(8	)

Net change in cash		—			158			(10	)		(89	)		—			59
Cash and cash equivalents at beginning of period		—			18			12			276			—			306
Cash and cash equivalents at end of period	$	—		$	176		$	13		$	187		$	—		$	365

Revenue Recognition (Details) - USD ($) $ in Millions	Jun. 29, 2019	Sep. 29, 2018
Revenue Recognition [Abstract]
Accrual for customer rebates	$ 60	$ 58

Acquisitions, Laddawn, Inc. (Details) - USD ($) $ in Millions	1 Months Ended
	Aug. 31, 2018	Jun. 29, 2019	Sep. 29, 2018
Acquisitions [Abstract]
Goodwill		$ 2,911	$ 2,944
Laddawn [Member]
Acquisitions [Abstract]
Purchase price	$ 241
Working capital	27
Property and equipment	39
Intangible assets	84
Goodwill	91
Step up of inventory to fair value	$ 3

Acquisitions, Clopay Plastic Products Company, Inc. (Details) - USD ($)
$ in Millions

1 Months Ended

Feb. 28, 2018

Jun. 29, 2019

Sep. 29, 2018

Jan. 31, 2018

Allocation of Purchase Price [Abstract]

Goodwill

$ 2,911

$ 2,944

4.50% Second Priority Senior Secured Notes due 2026 [Member]

Face amount of debt issued

$ 500

4.50%

Clopay [Member]

Allocation of Purchase Price [Abstract]

Purchase price

$ 475

Working capital

^[1]

Property and equipment

164

Intangible assets

125

Goodwill

111

Other assets and long-term liabilities

Step up of inventory to fair value

$ 3

[1]	Includes a $3 million step up of inventory to fair value

Accounts Receivable Factoring Agreements (Details) - USD ($) $ in Millions	Jun. 29, 2019	Sep. 29, 2018
Accounts Receivable Factoring Agreements [Abstract]
Amounts due from financial institutions	$ 0	$ 0
Trade receivables sold to financial institutions	$ 241	$ 162

Restructuring and Impairment Charges, Restructuring Charges by Segment (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 29, 2019	Jun. 30, 2018	Jun. 29, 2019	Jun. 30, 2018
Restructuring Charges [Abstract]
Restructuring charges	$ 2	$ 7	$ 18	$ 33
Engineered Materials [Member]
Restructuring Charges [Abstract]
Restructuring charges	0	2	1	4
Health, Hygiene & Specialties [Member]
Restructuring Charges [Abstract]
Restructuring charges	1	4	13	26
Consumer Packaging [Member]
Restructuring Charges [Abstract]
Restructuring charges	$ 1	$ 1	$ 4	$ 3

Restructuring and Impairment Charges, Restructuring Accrual Activity (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Jun. 29, 2019	Jun. 30, 2018	Jun. 29, 2019	Jun. 30, 2018	Sep. 29, 2018
Restructuring Accrual [Roll Forward]
Beginning balance			$ 13
Charges	$ 2	$ 7	18	$ 33
Non-cash asset impairment			(7)		$ 0
Cash payments			(16)
Ending balance	8		8		13
Employee Severance and Benefits [Member]
Restructuring Accrual [Roll Forward]
Beginning balance			9
Charges			7
Non-cash asset impairment			0
Cash payments			(13)
Ending balance	3		3		9
Facility Exit Costs [Member]
Restructuring Accrual [Roll Forward]
Beginning balance			4
Charges			4
Non-cash asset impairment			0
Cash payments			(3)
Ending balance	5		5		4
Non-Cash Impairment Charges [Member]
Restructuring Accrual [Roll Forward]
Beginning balance			0
Charges			7
Non-cash asset impairment			(7)
Cash payments			0
Ending balance	$ 0		$ 0		$ 0

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities, Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Millions	Jun. 29, 2019	Sep. 29, 2018
Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]
Derivative instruments	$ 138	$ 0
Employee compensation	99	113
Accrued taxes	66	72
Rebates	60	58
Interest	41	49
Tax receivable agreement obligation	12	16
Restructuring	8	13
Accrued operating expenses	98	95
Accrued expenses and other current liabilities	$ 522	$ 416

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities, Other Long-Term Liabilities (Details) - USD ($) $ in Millions	Jun. 29, 2019	Sep. 29, 2018
Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]
Derivative instruments	$ 79	$ 12
Uncertain tax positions	67	67
Deferred purchase price	45	40
Pension liability	42	45
Lease retirement obligation	41	39
Sale-lease back deferred gain	20	21
Transition tax	17	18
Tax receivable agreement obligation	10	23
Other	24	24
Other long-term liabilities	$ 345	$ 289

Long-Term Debt (Details) - USD ($)
$ in Millions

9 Months Ended

Jun. 29, 2019

Jun. 30, 2018

May 31, 2019

Apr. 30, 2019

Sep. 29, 2018

Debt discounts and deferred fees

$ (36)

$ (43)

Capital leases and other

106

135

Total long-term debt

5,468

5,844

Current portion of long-term debt

(29)

(38)

Long-term debt, less current portion

5,439

5,806

Repayments on long-term borrowings

383

$ 224

Term Loan due February 2020 [Member]

$ 450

800

Term Loan due January 2021 [Member]

^[1]

Feb. 29, 2020

$ 814

814

Term Loan due October 2022 [Member]

Jan. 31, 2021

$ 1,545

1,545

Term Loan due January 2024 [Member]

Oct. 31, 2022

$ 489

493

Revolving Line of Credit [Member]

Jan. 31, 2024

$ 0

Maximum borrowing capacity

May 31, 2024

$ 850

$ 750

5 1/2% Second Priority Senior Secured Notes due May 2022 [Member]

$ 500

500

5.50%

6% Second Priority Senior Secured Notes due October 2022 [Member]

May 31, 2022

$ 400

400

6.00%

5 1/8% Second Priority Senior Secured Notes due July 2023 [Member]

Oct. 31, 2022

$ 700

700

5.125%

4 1/2% Second Priority Senior Secured Notes due February 2026 [Member]

Jul. 31, 2023

$ 500

4.50%